Search

Augustine Kunle Obisesan

Examiner (ID: 8490, Phone: (571)272-2020 , Office: P/2156 )

Most Active Art Unit
2156
Art Unit(s)
2169, 2156
Total Applications
825
Issued Applications
506
Pending Applications
72
Abandoned Applications
275

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 16726576 [patent_doc_number] => 20210093723 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-01 [patent_title] => LIQUID COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 17/114104 [patent_app_country] => US [patent_app_date] => 2020-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8590 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17114104 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/114104
Liquid compositions Dec 6, 2020 Issued
Array ( [id] => 16883681 [patent_doc_number] => 20210169876 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-10 [patent_title] => TREATING LIVER DISEASE BY SELECTIVELY ELIMINATING SENESCENT CELLS [patent_app_type] => utility [patent_app_number] => 17/114379 [patent_app_country] => US [patent_app_date] => 2020-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 70218 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17114379 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/114379
Treating liver disease by selectively eliminating senescent cells Dec 6, 2020 Issued
Array ( [id] => 16883680 [patent_doc_number] => 20210169875 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-10 [patent_title] => TREATING CARDIOVASCULAR DISEASE BY SELECTIVELY ELIMINATING SENESCENT CELLS [patent_app_type] => utility [patent_app_number] => 17/114376 [patent_app_country] => US [patent_app_date] => 2020-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 70139 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17114376 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/114376
Treating cardiovascular disease by selectively eliminating senescent cells Dec 6, 2020 Issued
Array ( [id] => 17895372 [patent_doc_number] => 20220305034 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-29 [patent_title] => N-(PHENYLSULFONYL)BENZAMIDES AND RELATED COMPOUNDS AS BCL-2 INHIBITORS [patent_app_type] => utility [patent_app_number] => 17/287661 [patent_app_country] => US [patent_app_date] => 2020-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10483 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -48 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17287661 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/287661
N-(phenylsulfonyl)benzamides and related compounds as Bcl-2 inhibitors Dec 2, 2020 Issued
Array ( [id] => 18716475 [patent_doc_number] => 11793796 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-10-24 [patent_title] => Inhibition of crystal growth of roflumilast [patent_app_type] => utility [patent_app_number] => 17/102056 [patent_app_country] => US [patent_app_date] => 2020-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 6031 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17102056 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/102056
Inhibition of crystal growth of roflumilast Nov 22, 2020 Issued
Array ( [id] => 17043774 [patent_doc_number] => 11096933 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-08-24 [patent_title] => Method of treating disorders associated with chronic inflammation [patent_app_type] => utility [patent_app_number] => 17/084012 [patent_app_country] => US [patent_app_date] => 2020-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 23228 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17084012 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/084012
Method of treating disorders associated with chronic inflammation Oct 28, 2020 Issued
Array ( [id] => 19225409 [patent_doc_number] => 12005039 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-06-11 [patent_title] => Methods and compositions relating to lipokines for treating metabolic disorders [patent_app_type] => utility [patent_app_number] => 17/080528 [patent_app_country] => US [patent_app_date] => 2020-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 59 [patent_no_of_words] => 18246 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17080528 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/080528
Methods and compositions relating to lipokines for treating metabolic disorders Oct 25, 2020 Issued
Array ( [id] => 16822604 [patent_doc_number] => 20210137897 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-13 [patent_title] => TOPICAL mTOR INHIBITORS FOR CUTANEOUS PROLIFERATIVE AND VASCULAR CONDITIONS [patent_app_type] => utility [patent_app_number] => 17/076932 [patent_app_country] => US [patent_app_date] => 2020-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18425 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17076932 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/076932
TOPICAL mTOR INHIBITORS FOR CUTANEOUS PROLIFERATIVE AND VASCULAR CONDITIONS Oct 21, 2020 Abandoned
Array ( [id] => 16791613 [patent_doc_number] => 20210121430 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-29 [patent_title] => OMEGA-3 FATTY ACID SUPPLEMENTATION FOR USE IN TREATING DRY EYE [patent_app_type] => utility [patent_app_number] => 17/077463 [patent_app_country] => US [patent_app_date] => 2020-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9449 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 137 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17077463 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/077463
OMEGA-3 FATTY ACID SUPPLEMENTATION FOR USE IN TREATING DRY EYE Oct 21, 2020 Abandoned
Array ( [id] => 16619933 [patent_doc_number] => 20210038586 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-02-11 [patent_title] => VACUOLE-INDUCING COMPOUNDS, METHODS OF MAKING AND USING THE SAME [patent_app_type] => utility [patent_app_number] => 17/075065 [patent_app_country] => US [patent_app_date] => 2020-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5397 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17075065 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/075065
Vacuole-inducing compounds, methods of making and using the same Oct 19, 2020 Issued
Array ( [id] => 17052249 [patent_doc_number] => 20210261683 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-26 [patent_title] => METHOD OF TARGETING SPECIFIC CELL POPULATIONS USING CELL-BINDING AGENT MAYTANSINOID CONJUGATES LINKED VIA A NON-CLEAVABLE LINKER, SAID CONJUGATES AND METHODS OF MAKING SAID CONJUGATES [patent_app_type] => utility [patent_app_number] => 17/064981 [patent_app_country] => US [patent_app_date] => 2020-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13195 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17064981 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/064981
METHOD OF TARGETING SPECIFIC CELL POPULATIONS USING CELL-BINDING AGENT MAYTANSINOID CONJUGATES LINKED VIA A NON-CLEAVABLE LINKER, SAID CONJUGATES AND METHODS OF MAKING SAID CONJUGATES Oct 6, 2020 Abandoned
Array ( [id] => 16619965 [patent_doc_number] => 20210038618 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-02-11 [patent_title] => PROPHYLACTIC AND THERAPEUTIC TREATMENT OF ALZHEIMER'S DISEASE USING PHYTIC ACID AND PHYTATE TO REDUCE AMYLOID BETA PLAQUE AND TAU PROTEIN [patent_app_type] => utility [patent_app_number] => 17/064536 [patent_app_country] => US [patent_app_date] => 2020-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3296 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17064536 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/064536
Prophylactic and therapeutic treatment of alzheimer's disease using phytic acid and phytate to reduce amyloid beta plaque and tau protein Oct 5, 2020 Issued
Array ( [id] => 16581338 [patent_doc_number] => 20210015740 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-21 [patent_title] => TOPICAL CANNABINOID COMPOSITIONS, DELIVERY SYSTEMS, AND USES FOR PAIN RELIEF [patent_app_type] => utility [patent_app_number] => 17/036905 [patent_app_country] => US [patent_app_date] => 2020-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 51685 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -43 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17036905 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/036905
TOPICAL CANNABINOID COMPOSITIONS, DELIVERY SYSTEMS, AND USES FOR PAIN RELIEF Sep 28, 2020 Abandoned
Array ( [id] => 20142717 [patent_doc_number] => 12377032 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-08-05 [patent_title] => Compound for use in protecting skin [patent_app_type] => utility [patent_app_number] => 17/032616 [patent_app_country] => US [patent_app_date] => 2020-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 1860 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17032616 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/032616
Compound for use in protecting skin Sep 24, 2020 Issued
Array ( [id] => 17020838 [patent_doc_number] => 20210244709 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-12 [patent_title] => METHODS AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION [patent_app_type] => utility [patent_app_number] => 17/020196 [patent_app_country] => US [patent_app_date] => 2020-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 76090 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17020196 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/020196
METHODS AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION Sep 13, 2020 Abandoned
Array ( [id] => 16539321 [patent_doc_number] => 20200405734 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-31 [patent_title] => HOMOGENEOUS OPHTHALMIC COMPOSITION [patent_app_type] => utility [patent_app_number] => 17/018040 [patent_app_country] => US [patent_app_date] => 2020-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5499 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17018040 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/018040
Homogeneous ophthalmic composition Sep 10, 2020 Issued
Array ( [id] => 18666466 [patent_doc_number] => 11773344 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-10-03 [patent_title] => Terpene-based compositions, processes, methodologies for creation and products thereby [patent_app_type] => utility [patent_app_number] => 17/002666 [patent_app_country] => US [patent_app_date] => 2020-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 52954 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17002666 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/002666
Terpene-based compositions, processes, methodologies for creation and products thereby Aug 24, 2020 Issued
Array ( [id] => 18932487 [patent_doc_number] => 11884895 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-01-30 [patent_title] => Terpene-based compositions, methodologies for creation and products thereby [patent_app_type] => utility [patent_app_number] => 17/002606 [patent_app_country] => US [patent_app_date] => 2020-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 52931 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17002606 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/002606
Terpene-based compositions, methodologies for creation and products thereby Aug 24, 2020 Issued
Array ( [id] => 19777395 [patent_doc_number] => 12226415 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-02-18 [patent_title] => Methods and compositions for the treatment of hair loss [patent_app_type] => utility [patent_app_number] => 17/632973 [patent_app_country] => US [patent_app_date] => 2020-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 24001 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17632973 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/632973
Methods and compositions for the treatment of hair loss Aug 2, 2020 Issued
Array ( [id] => 16452454 [patent_doc_number] => 20200361880 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-11-19 [patent_title] => 1,2,4-Oxadiazole and Thiadiazole Compounds as Immunomodulators [patent_app_type] => utility [patent_app_number] => 16/945854 [patent_app_country] => US [patent_app_date] => 2020-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23370 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16945854 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/945854
1,2,4-oxadiazole and thiadiazole compounds as immunomodulators Jul 31, 2020 Issued
Menu